logo

Health Care News

Share

KemPharm Announces Positive Topline Data From Phase 1 Trial Evaluating Cardiovascular Safety Of Serdexmethylphenidate

Cara Therapeutics Submits NDA In Japan For Approval Of Difelikefalin For Pruritus In Hemodialysis

Revive Therapeutics Provides Update On Phase 3 Clinical Trial For Bucillamine In COVID-19

PepGen Reports Positive Data From Phase 1 Trial Of PGN-EDO51 For Duchenne Muscular Dystrophy

Ocular Therapeutix Announces Encouraging Interim Results From Phase 1 Trial Of OTX-TKI For Wet AMD

AstraZeneca Says Tezspire Approved In Japan For The Treatment Of Severe Asthma

Atea Pharma Announces FDA Fast Track Designation Granted To AT-752 For Treatment Of Dengue